|

RAdiation SEgmentectomy With REsin Microspheres (RASEREM) Study

RECRUITINGSponsored by Ankara University
Actively Recruiting
SponsorAnkara University
Started2025-08-01
Est. completion2028-03-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07345247

Summary

Radiation segmentectomy (RS) refers to selective infusion of Y-90 microspheres to the tumor bearing hepatic segment of hepatic artery. Majority of the data on RS is based on the Glass microspheres experience. Due to different properties of Resin and Glass microspheres description of dose limits to the segment for effectiveness of treatments with Resin microspheres are needed. Based on this background in this study it is aimed to evaluate the safety and efficacy of RS with resin microspheres in HCC patients. Secondly, it is planned to describe the dose limits for complete radiological response.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patients aged ≥18 years
* Underwent RE as a RS intent (have single or \<3 tumors in same or neighboring 2 segments) for the treatment of HCC or metastatic tumor to liver.
* Presence of extrahepatic disease
* Tumor size less than 8 cm
* Child Pugh Score \<B9

Exclusion Criteria:

* Presence of macrovascular invasion,
* Presence of extrahepatic disease,
* Cholangiocarcinoma or mixed HCC-cholangiocarcinoma
* Not willing to attend follow-up visits.

Conditions4

CancerLiver CancerLiver Cancer, AdultLiver Disease

Browse More Trials

Cancer trialsLiver Disease trialsLiver Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.